Abstract

A CLINICO COMPARATIVE STUDY ON THE ROLE OF VIRECANA WITH TRIVRTADI TARPANA AND KALAVASTI WITH KSIRADI PANCA PRASRTIKI NIRUHA AND MURCHITA TILA TAILA ANUVASANA IN THE MANAGEMENT OF PAKSAGHATA W.S.R. TO ISCHEMIC STROKE

Dr. M. Preethi Sudhan* and Dr. V. Lakshmana Prasad

.

Abstract

Current demographic trends suggest that the Indian population will survive through the peak years of occurrence of stroke (age 55-65 years) and stroke survivors in the elderly with varying degree of residual disability will be a major medical problem & is cause of 10- 20% of deaths disability. Among the survivors approximately half will recovers completely. The remaining half will be left with persistent major disability. Stroke is the first leading cause of disability and 3rd cause of mortality. About 700,000 strokes occur each year, over 167,000 deaths each year. The effects of a stroke depend on which part of the brain is injured and how severely it is affected.15 million people suffers from stroke worldwide each year of these 5 million die and another 5 million are permanently disabled. According to Āyurveda, Pakṣāghāta has been enlisted amongst the eighty types of Nānātmaja Vāta Vyādhi and is considered to be prominent of all Vāta Vyādhīs.[1] The condition similar to Pakṣāghāta in modern science is Hemiplegia. Virecana applied in Pakṣāghāta helps in pacifying the anubandha doṣa and provide anulomana to the deranged or vitiated Vāta. Though Virecana is specific purification for Pitta disorders but it also advised in various Vāta disorders in order to bring the Vāta doṣa into Anulomāvastā. Vasti is one of the important therapies for Vāta diseases in Ᾱyurveda.[2] Caraka mentioned Vasti as Ardha cikitsa. Ācārya Suśruta described Vasti is not only beneficial for Vāta, Pitta, Kapha, Rakta Vikāras but also Samsarga and Sannipāta diseases. Suśruta told its action is from head to toe like the drug remaining in the Pakvāśaya it draws the doṣas present from head to foot just as the sun remaining in the sky draws the sap from earth.[3] Taking the above points into consideration, the disease Pakṣāghāta was selected for present study to find better solution in hemiplegic patients. Methods: In the Present study, 60 patients of Pakṣāghāta were selected and were randomly allocated into two groups. In (Group-A) Administration of Dīpana Pācana drugs with Citrakādi vati, Snehapāna with Mūrchita tila taila continued till the Samyak Snigdha lakṣaṇas achieved, after that Sneha abhyaṉga and bhāṣpasvedam for 3 days with Bala Tailam followed by Virecana with Trivṛtādi Tarpana and Samsarjana krama. In (Group-B) Kṣīradi Pāñca Prasṛtikī Nirūha and Mūrchita Tila Taila Anuvāsana is given for 16 days in Kāla vasti format. Results: Though convincing results are exhibited by both groups in terms of bestowing relief to the patients, Group B (Vasti group) has shown relatively good results than Group A (Virecana group). Conclusion: The results conclude that (Group-B) Kṣīradi Pāñca Prasṛtikī Nirūha and Mūrchita Tila Taila Anuvāsana is observed as best for Pakṣāghāta without causing any adverse Drug Reactions and in improving the Functional ability in terms of mNIH and Barthel Index in relative terms to Group A (Virecana group).

Keywords: Pak??gh?ta, Triv?t?di Tarpana, Virecana, K??radi P?ñca Pras?tik? Nir?ha, M?rchita Tila Taila Anuv?sana Vasti.